Institutional Repository in Medical Sciences
(IRMS – Nicolae Testemițanu SUMPh)

Isoniazid monoresistantance - impact on treatment outcomes in patients with pulmonary tuberculosis

Isoniazid monoresistantance - impact on treatment outcomes in patients with pulmonary tuberculosis

Mironov, Tatiana; Donica, Ana
URI: https://medespera.asr.md/wp-content/uploads/Abastract-Book-2018.pdf
http://repository.usmf.md/handle/20.500.12710/11231
Date: 2018

Abstract:

Introduction. Isoniazid monoresistance is the most common type of single TB drug resistance worldwide. There is no strong evidence regarding the best treatment regimens in this group of patients.

Description:

Nicolae Testemitanu State University of Medicine and Pharmacy of the Republic of Moldova, Chiril Draganiuc Pneumophthysiology Institute of the Republic of Moldova

Show full item record

Files in this item

Icon
Name: Mironov_Donica_Is ...
Size: 507.4Kb
Format: PDF
View/Open

This item appears in the following Collection(s)

  • MedEspera 2018
    The 7th International Medical Congress for Students and Young Doctors, May 3-5, 2018

Search DSpace


Advanced Search

Browse

My Account

Statistics